Skip to main content
SpringerLink
Log in

Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

In patients with suspected urinary tract infection (UTI), antibiotic treatment is usually started empirically, before urine culture results are available. Unfortunately, antibiotic resistance has become an increasingly pressing clinical issue in many countries. The objective of this study was to assess the changing susceptibility of urinary pathogens to commonly used antimicrobials in a six-year period to evaluate the options for empirical antibiotic therapy in children with community acquired UTI.

Material and methods

A retrospective analysis of data from all pediatric urine samples processed at Fatih University Medical School microbiology laboratory was undertaken for a period of six years (January 2000–December 2006).

Results

A total of 767 urinary pathogens were isolated from 767 episodes of UTI in 698 patients. The most common causative agent was Escherichia coli (E. coli) followed by Klebsiella spp. and others. In 2000 almost 60% of the E. coli isolates were susceptible to ampicillin (AMP), more than 40% to Co-trimoxazole (SXT), more than 80% to gentamicin (GN), more than 90% to cefuroxime (CXM) and amikacin (AN), and more than 60% to piperacillin (PIP). By 2006 more than 70% were resistant to AMP and more than 50% were resistant to PIP. In 2000 CIP (2.7% resistant isolates) and CXM (3.4% resistant isolates) were the most active agents against Klebsiella spp.; and none of the isolates was found to be resistant to imipenem (IMP). In 2006 GN (2.7% resistant isolates), CIP (3.5% resistant isolates), CXM (2.7% resistant isolates), and AN (8.9% resistant isolates) were the most active agents against these species and still no resistance to IMP was found. For E. Coli the increase in resistance to AMP, CTX, IMP, and PIP was statistically significant (P < 0.05). For Klebsiella spp. the increase in resistance to AMP and CXM was statistically significant (P < 0.05).

Conclusions

Empirical antibiotic selection should be based on knowledge of the local prevalence of bacterial organisms and antibiotic sensitivities, because resistance patterns may vary in different regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Elder JS (2000) Urologic disorders in infants and children. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. WB Saunders, Philadelphia, pp 1621–1625

    Google Scholar 

  2. Adjei O, Opoku C (2004) Urinary tract infections in African infants. Int J Antimicrob Agents 24:32–34. doi:10.1016/j.ijantimicag.2004.02.007

    Article  CAS  Google Scholar 

  3. Allen UD, MacDonald N et al (1999) Risk factors for resistance to ‘first-line’ antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 160:1436–1440

    CAS  PubMed  Google Scholar 

  4. Haller M, Brandis M, Berner R (2004) Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol 19:982–986. doi:10.1007/s00467-004-1528-7

    Article  PubMed  Google Scholar 

  5. Ladhani S, Gransden W (2003) Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 88:444–445. doi:10.1136/adc.88.5.444

    Article  CAS  PubMed  Google Scholar 

  6. National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved Standard. M100-S12. NCCLS, Wayne, PA

  7. Grunberg RN (1994) Changes in urinary pathogens and their antibiotic sensitivities, 1971–1992. J Antimicrob Chemother 33:1–8. doi:10.1093/jac/33.1.1

    Article  Google Scholar 

  8. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359–365. doi:10.1093/jac/44.3.359

    Article  CAS  PubMed  Google Scholar 

  9. Beunders AJ (1994) Development of antibacterial resistance. The Dutch experience. J Antimicrob Chemother 33:17–22

    PubMed  Google Scholar 

  10. Winstanley TG, Limb DI et al (1997) A 10-year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J Antimicrob Chemother 40:591–594. doi:10.1093/jac/40.4.591

    Article  CAS  PubMed  Google Scholar 

  11. Gupta K, Scholes D et al (1999) Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281:736–738. doi:10.1001/jama.281.8.736

    Article  CAS  PubMed  Google Scholar 

  12. Weber G, Riesenberg K et al (1997) Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991–1995. Eur J Clin Microbiol Infect Dis 16:834–835. doi:10.1007/BF01700414

    Article  CAS  PubMed  Google Scholar 

  13. Prais D, Straussberg R et al (2003) Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 88:215–218. doi:10.1136/adc.88.3.215

    Article  CAS  PubMed  Google Scholar 

  14. Carapetis JR, Jaquiery AL et al (2001) Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatr Infect Dis J 20:240–246. doi:10.1097/00006454-200103000-00004

    Article  CAS  PubMed  Google Scholar 

  15. Bronzwaer SL, Cars O, and participants in the European Antimicrobial Surveillance System et al (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278–282

    Article  PubMed  Google Scholar 

  16. Patterson JE (2002) Extended spectrum beta-lactamases: a therapeutic dilemma. Pediatr Infect Dis J 21:957–959. doi:10.1097/00006454-200210000-00014

    Article  PubMed  Google Scholar 

  17. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1–14. doi:10.1128/AAC.48.1.1-14.2004

    Article  CAS  PubMed  Google Scholar 

  18. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH (2000) Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 21:455–458. doi:10.1086/501787

    Article  CAS  PubMed  Google Scholar 

  19. Toltzis P, Dul M et al (2003) Cefepime use in pediatric intensive care unit reduces colonization with resistant bacilli. Pediatr Infect Dis J 22:109–114

    PubMed  Google Scholar 

  20. Swartz MN (1997) Use of antimicrobial agents and drug resistance. N Engl J Med 337:491–492. doi:10.1056/NEJM199708143370709

    Article  CAS  PubMed  Google Scholar 

  21. Goldmann DA, Weinstein RA et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. Workshop to Prevent, Control the Emergence, Spread of Antimicrobial-Resistant Microorganisms in Hospitals. JAMA 275:234–240. doi:10.1001/jama.275.3.234

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Fatih University Medical School, Ankara, Turkey

    Ferhat Catal, Musemma Karabel, Duran Karabel & Ender Odemis

  2. Department of Nephrology, Fatih University Medical School, Ankara, Turkey

    Nuket Bavbek & Ebru Uz

  3. Dikmen Yıldızı Sokak 10/8, 06460, DİKMEN/Ankara, Turkey

    Nuket Bavbek

  4. Department of Urology, Fatih University Medical School, Ankara, Turkey

    Omer Bayrak

Authors
  1. Ferhat Catal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nuket Bavbek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Omer Bayrak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Musemma Karabel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Duran Karabel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ender Odemis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ebru Uz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuket Bavbek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catal, F., Bavbek, N., Bayrak, O. et al. Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006. Int Urol Nephrol 41, 953–957 (2009). https://doi.org/10.1007/s11255-008-9445-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9445-5

Keywords

Search

Navigation